Literature DB >> 8457245

Antibodies to cytoskeletal proteins in sera of patients with angiographically assessed coronary artery disease.

S T Nikkari1, T Solakivi, T Sisto, O Jaakkola.   

Abstract

Circulating autoantibodies to various components of the arterial wall have been reported in atherosclerosis. To examine the occurrence of autoantibodies to cytoskeletal proteins in coronary artery disease (CAD) we studied 56 patients with angiographically demonstrable CAD and compared them with 37 controls without CAD. Enzyme-linked immunosorbent assay (ELISA) was used to analyze the serum samples. In coronary patients, antibody absorbance values at least two standard deviations above the mean for the controls were considered positive. The following numbers of positive antibody absorbances were found in the group of 56 patients: actin IgG, 6 (10.7%); cytokeratin-18 IgG, 3 (5.4%), IgA, 2 (3.6%); myosin IgA, 11 (19.6%); desmin IgG, 13 (23.2%), IgM, 3 (5.4%); vimentin IgG, 2 (3.6%), IgM, 7 (12.5%), IgA, 6 (10.7%). The specificity of desmin IgG was tested with Western blotting against extracts of human internal mammary artery. The positive antibody absorbances to one or several cytoskeletal proteins in the patients were not found to correlate with the clinical symptoms of CAD. Our results suggest an association between autoantibodies to cytoskeletal proteins, particularly to those for desmin, with angiographically assessable CAD.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8457245     DOI: 10.1016/0021-9150(93)90218-j

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  4 in total

1.  High titres of serum antinuclear antibodies, mostly directed against nucleolar antigens, are associated with the presence of coronary atherosclerosis.

Authors:  D J Grainger; H W L Bethell
Journal:  Ann Rheum Dis       Date:  2002-02       Impact factor: 19.103

2.  BPIFB1 is a lung-specific autoantigen associated with interstitial lung disease.

Authors:  Anthony K Shum; Mohammad Alimohammadi; Catherine L Tan; Mickie H Cheng; Todd C Metzger; Christopher S Law; Wint Lwin; Jaakko Perheentupa; Helene Bour-Jordan; Jean Claude Carel; Eystein S Husebye; Filippo De Luca; Christer Janson; Ravishankar Sargur; Noémie Dubois; Merja Kajosaari; Paul J Wolters; Harold A Chapman; Olle Kämpe; Mark S Anderson
Journal:  Sci Transl Med       Date:  2013-10-09       Impact factor: 17.956

3.  Increased levels of antibodies to cytokeratin 18 in patients with rheumatoid arthritis and ischaemic heart disease.

Authors:  D L Mattey; P T Dawes; N B Nixon; L Goh; M J Banks; G D Kitas
Journal:  Ann Rheum Dis       Date:  2004-04       Impact factor: 19.103

4.  Vimentin and Anti Vimentin Antibodies in Chagas' Disease.

Authors:  Marilda Savoia Nascimento; Anna Maria Simonsen Stolf; Heitor Franco de Andrade Junior; Ramendra Pati Pandey; Eufrosina Setsu Umezawa
Journal:  Arq Bras Cardiol       Date:  2018-03-12       Impact factor: 2.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.